US Supreme Court To Hear Arguments On Pay-For-Delay Drug Deals
The United States Supreme Court is scheduled to hear oral arguments on Monday in a case in which the US Federal Trade Commission is questioning payments made by brand name pharmaceutical companies to generic producers for delayed entry into the market of lower priced generics.
